Black Diamond Therapeutics (BDTX) EBITDA Margin (2025)
Black Diamond Therapeutics' EBITDA Margin came in at 18.35% for FY2025.
Powered by 
Analysis
Black Diamond Therapeutics (BDTX) EBITDA Margin (2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 39.16% |
| 10 | Black Diamond Therapeutics | 121.04 Mn | -371.87 Mn | - | - |
API Access
Black Diamond Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BDTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BDTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BDTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();